HIV and HLA Class I: An Evolving Relationship

Immunity

Volumn 37, Issue 3, 2012, Pages 426-440

  Goulder, Philip J R ^a,b,c   Walker, Bruce D ^a,c,d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA A ANTIGEN; HLA A25 ANTIGEN; HLA A32 ANTIGEN; HLA A36 ANTIGEN; HLA A74 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA B07 ANTIGEN; HLA B08 ANTIGEN; HLA B13 ANTIGEN; HLA B14 ANTIGEN; HLA B18 ANTIGEN; HLA B27 ANTIGEN; HLA B35 ANTIGEN; HLA B42 ANTIGEN; HLA B44 ANTIGEN; HLA B45 ANTIGEN; HLA B51 ANTIGEN; HLA B52 ANTIGEN; HLA B53 ANTIGEN; HLA B54 ANTIGEN; HLA B57 ANTIGEN; HLA B58 ANTIGEN; HLA B81 ANTIGEN; HLA C ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN EXPRESSION; CD8+ T LYMPHOCYTE; CLADISTICS; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN MOTIF; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; VIREMIA; VIRUS CELL INTERACTION; VIRUS LOAD;

AIDS VACCINES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; HIV INFECTIONS; HLA-B ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION;

EID: 84866490075     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.09.005     Document Type: Review

References (136)

1. *01: implications for vaccine design and testing. J. Virol. 2001, 75:738-749.
2. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., Asher T.E., Samri A., Schnuriger A., Theodorou I., et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 2007, 204:2473-2485.
3. Alter G., Heckerman D., Schneidewind A., Fadda L., Kadie C.M., Carlson J.M., Oniangue-Ndza C., Martin M., Li B., Khakoo S.I., et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011, 476:96-100.
4. Altfeld M., Goulder P. 'Unleashed' natural killers hinder HIV. Nat. Genet. 2007, 39:708-710.
5. Altfeld M., Kalife E.T., Qi Y., Streeck H., Lichterfeld M., Johnston M.N., Burgett N., Swartz M.E., Yang A., Alter G., et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med. 2006, 3:e403.
6. *27-positive individuals predicts viral load outcome. J. Immunol. 2011, 186:479-488.
7. *57+ elite suppressors. J. Virol. 2009, 83:88-97.
8. Bennett M.S., Ng H.L., Ali A., Yang O.O. Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity. J. Infect. Dis. 2008, 197:390-397.
9. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
10. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
11. Blanco-Gelaz M.A., Suárez-Alvarez B., González S., López-Vázquez A., Martínez-Borra J., López-Larrea C. The amino acid at position 97 is involved in folding and surface expression of HLA-B27. Int. Immunol. 2006, 18:211-220.
12. *0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J. Virol. 1999, 73:10191-10198.
13. Carlson J.M., Listgarten J., Pfeifer N., Tan V., Kadie C., Walker B.D., Ndung'u T., Shapiro R., Frater J., Brumme Z.L., et al. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J. Virol. 2012, 86:5230-5243.
14. Carrington M., Walker B.D. Immunogenetics of spontaneous control of HIV. Annu. Rev. Med. 2012, 63:131-145.
15. *04 disadvantage. Science 1999, 283:1748-1752.
16. Carrington M., Martin M.P., van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008, 16:620-627.
17. Chen H., Piechocka-Trocha A., Miura T., Brockman M.A., Julg B.D., Baker B.M., Rothchild A.C., Block B.L., Schneidewind A., Koibuchi T., et al. Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes. J. Virol. 2009, 83:3138-3149.
18. Chen D.Y., Balamurugan A., Ng H.L., Yang O.O. Antiviral activity of human immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not necessarily intrinsically superior to envelope targeting. J. Virol. 2011, 85:2474-2478.
19. Chen D.Y., Balamurugan A., Ng H.L., Cumberland W.G., Yang O.O. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from CTLs. Blood 2012, 120:100-111.
20. Chen H., Ndhlovu Z.M., Liu D., Porter L.C., Fang J.W., Darko S., Brockman M.A., Miura T., Brumme Z.L., Schneidewind A., et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 2012, 13:691-700.
21. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671.
22. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391:397-401.
23. Corrah T.W., Goonetilleke N., Kopycinski J., Deeks S.G., Cohen M.S., Borrow P., McMichael A., Brackenridge S. Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J. Virol. 2011, 85:3367-3374.
24. *5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS 1999, 13:1990-1991.
25. *5703-positive individuals and their transmission recipients. J. Exp. Med. 2009, 206:909-921.
26. Dalmasso C., Carpentier W., Meyer L., Rouzioux C., Goujard C., Chaix M.L., Lambotte O., Avettand-Fenoel V., Le Clerc S., de Senneville L.D., et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS ONE 2008, 3:e3907. ANRS Genome Wide Association 01.
27. de Bakker P.I., McVean G., Sabeti P.C., Miretti M.M., Green T., Marchini J., Ke X., Monsuur A.J., Whittaker P., Delgado M., et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 2006, 38:1166-1172.
28. Dinges W.L., Richardt J., Friedrich D., Jalbert E., Liu Y., Stevens C.E., Maenza J., Collier A.C., Geraghty D.E., Smith J., et al. Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J. Virol. 2010, 84:4461-4468.
29. Doherty P.C., Zinkernagel R.M. A biological role for the major histocompatibility antigens. Lancet 1975, 1:1406-1409.
30. Dorak M.T., Tang J., Tang S., Penman-Aguilar A., Coutinho R.A., Goedert J.J., Detels R., Kaslow R.A. Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white men. J. Infect. Dis. 2003, 188:856-863.
31. Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M., et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 2004, 199:905-915.
32. Edwards B.H., Bansal A., Sabbaj S., Bakari J., Mulligan M.J., Goepfert P.A. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 2002, 76:2298-2305.
33. Elahi S., Dinges W.L., Lejarcegui N., Laing K.J., Collier A.C., Koelle D.M., McElrath M.J., Horton H. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat. Med. 2011, 17:989-995.
34. Emu B., Sinclair E., Hatano H., Ferre A., Shacklett B., Martin J.N., McCune J.M., Deeks S.G. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J. Virol. 2008, 82:5398-5407.
35. Fagerberg T., Cerottini J.C., Michielin O. Structural prediction of peptides bound to MHC class I. J. Mol. Biol. 2006, 356:521-546.
36. Feeney M.E., Tang Y., Roosevelt K.A., Leslie A.J., McIntosh K., Karthas N., Walker B.D., Goulder P.J. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 2004, 78:8927-8930.
37. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947.
38. Fellay J., Ge D., Shianna K.V., Colombo S., Ledergerber B., Cirulli E.T., Urban T.J., Zhang K., Gumbs C.E., Smith J.P., et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 2009, 5:e1000791. NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI).
39. Flores-Villanueva P.O., Yunis E.J., Delgado J.C., Vittinghoff E., Buchbinder S., Leung J.Y., Uglialoro A.M., Clavijo O.P., Rosenberg E.S., Kalams S.A., et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA 2001, 98:5140-5145.
40. Gao X., Nelson G.W., Karacki P., Martin M.P., Phair J., Kaslow R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 2001, 344:1668-1675.
41. Gao X., Bashirova A., Iversen A.K., Phair J., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Altfeld M., O'Brien S.J., Carrington M. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med. 2005, 11:1290-1292.
42. Geldmacher C., Currier J.R., Herrmann E., Haule A., Kuta E., McCutchan F., Njovu L., Geis S., Hoffmann O., Maboko L., et al. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J. Virol. 2007, 81:2440-2448.
43. Goulder P.J., Bunce M., Krausa P., McIntyre K., Crowley S., Morgan B., Edwards A., Giangrande P., Phillips R.E., McMichael A.J. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 1996, 12:1691-1698.
44. Goulder P.J., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A., et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 1997, 3:212-217.
45. Goulder P.J., Brander C., Annamalai K., Mngqundaniso N., Govender U., Tang Y., He S., Hartman K.E., O'Callaghan C.A., Ogg G.S., et al. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J. Virol. 2000, 74:5679-5690.
46. Goulder P.J., Brander C., Tang Y., Tremblay C., Colbert R.A., Addo M.M., Rosenberg E.S., Nguyen T., Allen R., Trocha A., et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001, 412:334-338.
47. Harrer T., Harrer E., Kalams S.A., Barbosa P., Trocha A., Johnson R.P., Elbeik T., Feinberg M.B., Buchbinder S.P., Walker B.D. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 1996, 156:2616-2623.
48. Hendel H., Caillat-Zucman S., Lebuanec H., Carrington M., O'Brien S., Andrieu J.M., Schächter F., Zagury D., Rappaport J., Winkler C., et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J. Immunol. 1999, 162:6942-6946.
49. Hersperger A.R., Martin J.N., Shin L.Y., Sheth P.M., Kovacs C.M., Cosma G.L., Makedonas G., Pereyra F., Walker B.D., Kaul R., et al. Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood 2011, 117:3799-3808.
50. Hindorff L.A., MacArthur J. (European Bioinformatics Institute), Wise, A., Junkins, H.A., Hall, P.N., Klemm, A.K., and Manolio, T.A. (2012). A Catalog of Published Genome-Wide Association Studies. http://www.genome.gov/gwastudies.
51. *13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J. Virol. 2007, 81:3667-3672.
52. Horton H., Frank I., Baydo R., Jalbert E., Penn J., Wilson S., McNevin J.P., McSweyn M.D., Lee D., Huang Y., et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J. Immunol. 2006, 177:7406-7415.
53. *35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J. Exp. Med. 2009, 206:2959-2966.
54. Huang J., Burke P.S., Cung T.D., Pereyra F., Toth I., Walker B.D., Borges L., Lichterfeld M., Yu X.G. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J. Virol. 2010, 84:9463-9471.
55. Hughes A.L., Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988, 335:167-170.
56. Iglesias M.C., Almeida J.R., Fastenackels S., van Bockel D.J., Hashimoto M., Venturi V., Gostick E., Urrutia A., Wooldridge L., Clement M., et al. Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood 2011, 118:2138-2149.
57. Ishii H., Kawada M., Tsukamoto T., Yamamoto H., Matsuoka S., Shiino T., Takeda A., Inoue M., Iida A., Hara H., et al. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques. J. Virol. 2012, 86:738-745.
58. Kaslow R.A., Carrington M., Apple R., Park L., Muñoz A., Saah A.J., Goedert J.J., Winkler C., O'Brien S.J., Rinaldo C., et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 1996, 2:405-411.
59. Kawada M., Tsukamoto T., Yamamoto H., Takeda A., Igarashi H., Watkins D.I., Matano T. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine. J. Virol. 2007, 81:5202-5211.
60. Kawada M., Tsukamoto T., Yamamoto H., Iwamoto N., Kurihara K., Takeda A., Moriya C., Takeuchi H., Akari H., Matano T. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J. Virol. 2008, 82:10199-10206.
61. Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A., Koizumi H., et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458:641-645.
62. *5101. J. Virol. 2010, 84:7151-7160.
63. Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004, 432:769-775.
64. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007, 13:46-53.
65. Klein M.R., van Baalen C.A., Holwerda A.M., Kerkhof Garde S.R., Bende R.J., Keet I.P., Eeftinck-Schattenkerk J.K., Osterhaus A.D., Schuitemaker H., Miedema F. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 1995, 181:1365-1372.
66. Klenerman P., Luzzi G., McIntyre K., Phillips R., McMichael A. Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80). AIDS 1996, 10:348-350.
67. Kløverpris H.N., Harndahl M., Leslie A.J., Carlson J.M., Ismail N., van der Stok M., Huang K.H., Chen F., Riddell L., Steyn D., et al. HIV control through a single nucleotide on the HLA-B locus. J. Virol. 2012, in press. Published online August 15, 2012. JVI.01020-12.
68. *7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania. J. Infect. Dis. 2010, 202:1562-1566.
69. Kosmrlj A., Read E.L., Qi Y., Allen T.M., Altfeld M., Deeks S.G., Pereyra F., Carrington M., Walker B.D., Chakraborty A.K. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 2010, 465:350-354.
70. Kulkarni S., Savan R., Qi Y., Gao X., Yuki Y., Bass S.E., Martin M.P., Hunt P., Deeks S.G., Telenti A., et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011, 472:495-498.
71. Lazaro E., Godfrey S.B., Stamegna P., Ogbechie T., Kerrigan C., Zhang M., Walker B.D., Le Gall S. Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition. J. Infect. Dis. 2009, 200:236-243.
72. Lazaryan A., Lobashevsky E., Mulenga J., Karita E., Allen S., Tang J., Kaslow R.A. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J. Virol. 2006, 80:6056-6060.
73. Lazaryan A., Song W., Lobashevsky E., Tang J., Shrestha S., Zhang K., McNicholl J.M., Gardner L.I., Wilson C.M., Klein R.S., et al. The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum. Immunol. 2011, 72:312-318. HIV Epidemiology Research Study Group, Reaching for Excellence in Adolescent Care and Health Study GroupReaching for Excellence in Adolescent Care and Health Study Group.
74. Le Gall S., Stamegna P., Walker B.D. Portable flanking sequences modulate CTL epitope processing. J. Clin. Invest. 2007, 117:3563-3575.
75. Leslie A., Price D.A., Mkhize P., Bishop K., Rathod A., Day C., Crawford H., Honeyborne I., Asher T.E., Luzzi G., et al. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J. Immunol. 2006, 177:4699-4708.
76. Leslie A., Matthews P.C., Listgarten J., Carlson J.M., Kadie C., Ndung'u T., Brander C., Coovadia H., Walker B.D., Heckerman D., Goulder P.J. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J. Virol. 2010, 84:9879-9888.
77. Lichterfeld M., Yu X.G. The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection. J. Leukoc. Biol. 2012, 91:27-33.
78. Lichterfeld M., Kaufmann D.E., Yu X.G., Mui S.K., Addo M.M., Johnston M.N., Cohen D., Robbins G.K., Pae E., Alter G., et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med. 2004, 200:701-712.
79. Limou S., Le Clerc S., Coulonges C., Carpentier W., Dina C., Delaneau O., Labib T., Taing L., Sladek R., Deveau C., et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J. Infect. Dis. 2009, 199:419-426. ANRS Genomic Group.
80. Madden D.R., Garboczi D.N., Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993, 75:693-708.
81. *17-positive simian immunodeficiency virus-infected rhesus macaques. J. Virol. 2008, 82:5245-5254.
82. Marsh S.G.E., Parham P., Barber L.D. The HLA Factsbook 2000, Academic Press, San Diego.
83. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 2002, 31:429-434.
84. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., Colombo S., Brown E.E., Shupert W.L., Phair J., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 2007, 39:733-740.
85. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 2006, 80:3617-3623.
86. Masemola A., Mashishi T., Khoury G., Mohube P., Mokgotho P., Vardas E., Colvin M., Zijenah L., Katzenstein D., Musonda R., et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 2004, 78:3233-3243. HIVNET 028 Study Team.
87. Matano T., Kobayashi M., Igarashi H., Takeda A., Nakamura H., Kano M., Sugimoto C., Mori K., Iida A., Hirata T., et al. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 2004, 199:1709-1718.
88. *5703. J. Immunol. 2011, 186:5675-5686.
89. McLaren P.J., Ripke S., Pelak K., Weintrob A.C., Patsopoulos N.A., Jia X., Erlich R.L., Lennon N.J., Kadie C.M., Heckerman D., et al. Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. Hum. Mol. Genet. 2012, and the International HIV Controllers Study, in press. Published online June 19, 2012. 10.1093/hmg/dds226.
90. Mendoza D., Johnson S.A., Peterson B.A., Natarajan V., Salgado M., Dewar R.L., Burbelo P.D., Doria-Rose N.A., Graf E.H., Greenwald J.H., et al. Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood 2012, 119:4645-4655.
91. *5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA 2000, 97:2709-2714.
92. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C.W., Van Baarle D., Kostense S., Miedema F., McLaughlin M., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 2002, 3:1061-1068.
93. Migueles S.A., Osborne C.M., Royce C., Compton A.A., Joshi R.P., Weeks K.A., Rood J.E., Berkley A.M., Sacha J.B., Cogliano-Shutta N.A., et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008, 29:1009-1021.
94. Miura T., Brockman M.A., Brumme Z.L., Brumme C.J., Pereyra F., Trocha A., Block B.L., Schneidewind A., Allen T.M., Heckerman D., Walker B.D. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J. Virol. 2009, 83:140-149.
95. *5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J. Virol. 2009, 83:2743-2755.
96. Miura T., Brumme C.J., Brockman M.A., Brumme Z.L., Pereyra F., Block B.L., Trocha A., John M., Mallal S., Harrigan P.R., Walker B.D. HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers. J. Virol. 2009, 83:3407-3412.
97. Mudd P.A., Ericsen A.J., Walsh A.D., León E.J., Wilson N.A., Maness N.J., Friedrich T.C., Watkins D.I. CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission. J. Virol. 2011, 85:12804-12810.
98. Mudd P.A., Martins M.A., Ericsen A.J., Tully D.C., Power K.A., Bean A.T., Piaskowski S.M., Duan L., Seese A., Gladden A.D., et al. Vaccine-induced CD81 T cells control AIDS virus replication. Nature 2012, 10.1038/nature11443.
99. *5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res. Hum. Retroviruses 2008, 24:72-82.
100. Nixon D.F., Townsend A.R., Elvin J.G., Rizza C.R., Gallwey J., McMichael A.J. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988, 336:484-487.
101. Nomura T., Matano T. Association of MHC-I genotypes with disease progression in HIV/SIV infections. Front Microbiol. 2012, 3:234.
102. *5701 subjects. J. Virol. 2012, 86:9802-9816.
103. Novitsky V., Gilbert P., Peter T., McLane M.F., Gaolekwe S., Rybak N., Thior I., Ndung'u T., Marlink R., Lee T.H., Essex M. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J. Virol. 2003, 77:882-890.
104. O'Brien S.J., Gao X., Carrington M. HLA and AIDS: a cautionary tale. Trends Mol. Med. 2001, 7:379-381.
105. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y., Rowland-Jones S.L., Cerundolo V., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279:2103-2106.
106. Parsons M.S., Wren L., Isitman G., Navis M., Stratov I., Bernard N.F., Kent S.J. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J. Virol. 2012, 86:4488-4495.
107. Payne R.P., Kløverpris H., Sacha J.B., Brumme Z., Brumme C., Buus S., Sims S., Hickling S., Riddell L., Chen F., et al. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J. Virol. 2010, 84:10543-10557.
108. Pelak K., Goldstein D.B., Walley N.M., Fellay J., Ge D., Shianna K.V., Gumbs C., Gao X., Maia J.M., Cronin K.D., et al. Host determinants of HIV-1 control in African Americans. J. Infect. Dis. 2010, 201:1141-1149. Infectious Disease Clinical Research Program HIV Working Group, National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology (CHAVI)National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology (CHAVI).
109. Pereyra F., Addo M.M., Kaufmann D.E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 2008, 197:563-571.
110. Pereyra F., Jia X., McLaren P.J., Telenti A., de Bakker P.I., Walker B.D., Ripke S., Brumme C.J., Pulit S.L., Carrington M., et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557. International HIV Controllers Study.
111. Rivière Y., McChesney M.B., Porrot F., Tanneau-Salvadori F., Sansonetti P., Lopez O., Pialoux G., Feuillie V., Mollereau M., Chamaret S., et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses 1995, 11:903-907.
112. Robinson J., Mistry K., McWilliam H., Lopez R., Parham P., Marsh S.G. The IMGT/HLA database. Nucleic Acids Res. 2011, 39(Database issue):D1171-D1176.
113. Sacha J.B., Chung C., Rakasz E.G., Spencer S.P., Jonas A.K., Bean A.T., Lee W., Burwitz B.J., Stephany J.J., Loffredo J.T., et al. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 2007, 178:2746-2754.
114. Sacha J.B., Chung C., Reed J., Jonas A.K., Bean A.T., Spencer S.P., Lee W., Vojnov L., Rudersdorf R., Friedrich T.C., et al. Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation. J. Virol. 2007, 81:11703-11712.
115. Sáez-Cirión A., Lacabaratz C., Lambotte O., Versmisse P., Urrutia A., Boufassa F., Barré-Sinoussi F., Delfraissy J.-F., Sinet M., Pancino G., Venet A. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. USA 2007, 104:6776-6781. Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group.
116. Schneidewind A., Brockman M.A., Yang R., Adam R.I., Li B., Le Gall S., Rinaldo C.R., Craggs S.L., Allgaier R.L., Power K.A., et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 2007, 81:12382-12393.
117. Schneidewind A., Brockman M.A., Sidney J., Wang Y.E., Chen H., Suscovich T.J., Li B., Adam R.I., Allgaier R.L., Mothé B.R., et al. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 2008, 82:5594-5605.
118. Shrestha S., Aissani B., Song W., Wilson C.M., Kaslow R.A., Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009, 23:673-677.
119. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008, 9:1.
120. Smith M.Z., Dale C.J., De Rose R., Stratov I., Fernandez C.S., Brooks A.G., Weinfurter J., Krebs K., Riek C., Watkins D.I., et al. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol. 2005, 79:684-695.
121. Steel C.M., Ludlam C.A., Beatson D., Peutherer J.F., Cuthbert R.J., Simmonds P., Morrison H., Jones M. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988, 1:1185-1188.
122. Steers N.J., Currier J.R., Kijak G.H., di Targiani R.C., Saxena A., Marovich M.A., Kim J.H., Michael N.L., Alving C.R., Rao M. Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire. J. Virol. 2011, 85:1541-1553.
123. *5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J. Immunol. 2005, 175:2459-2468.
124. Streeck H., Lichterfeld M., Alter G., Meier A., Teigen N., Yassine-Diab B., Sidhu H.K., Little S., Kelleher A., Routy J.P., et al. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J. Virol. 2007, 81:7725-7731.
125. Tang J., Malhotra R., Song W., Brill I., Hu L., Farmer P.K., Mulenga J., Allen S., Hunter E., Kaslow R.A. Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS ONE 2010, 5:e9629.
126. Thomas R., Apps R., Qi Y., Gao X., Male V., O'Huigin C., O'Connor G., Ge D., Fellay J., Martin J.N., et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 2009, 41:1290-1294.
127. Troyer R.M., McNevin J., Liu Y., Zhang S.C., Krizan R.W., Abraha A., Tebit D.M., Zhao H., Avila S., Lobritz M.A., et al. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 2009, 5:e1000365.
128. Tsukamoto T., Takeda A., Yamamoto T., Yamamoto H., Kawada M., Matano T. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques. J. Virol. 2009, 83:9339-9346.
129. Valentine L.E., Watkins D.I. Relevance of studying T cell responses in SIV-infected rhesus macaques. Trends Microbiol. 2008, 16:605-611.
130. *08-positive macaques. J. Virol. 2009, 83:11514-11527.
131. Yang O.O., Kalams S.A., Rosenzweig M., Trocha A., Jones N., Koziel M., Walker B.D., Johnson R.P. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 1996, 70:5799-5806.
132. Yang O.O., Kalams S.A., Trocha A., Cao H., Luster A., Johnson R.P., Walker B.D. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 1997, 71:3120-3128.
133. Yang O.O., Nguyen P.T., Kalams S.A., Dorfman T., Göttlinger H.G., Stewart S., Chen I.S., Threlkeld S., Walker B.D. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J. Virol. 2002, 76:1626-1631.
134. Yang O.O., Sarkis P.T., Ali A., Harlow J.D., Brander C., Kalams S.A., Walker B.D. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 2003, 197:1365-1375.
135. Zinkernagel R.M., Doherty P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974, 248:701-702.
136. Zuñiga R., Lucchetti A., Galvan P., Sanchez S., Sanchez C., Hernandez A., Sanchez H., Frahm N., Linde C.H., Hewitt H.S., et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J. Virol. 2006, 80:3122-3125.